Cholesterol, LDL

"Cholesterol, LDL" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Cholesterol which is contained in or bound to low density lipoproteins (LDL), including CHOLESTEROL ESTERS and free cholesterol.

Descriptor ID	D008078
MeSH Number(s)	D04.210.500.247.808.197.244 D10.532.515.500 D10.570.938.208.275 D12.776.521.550.500
Concept/Terms	Cholesterol, LDL Cholesterol, LDL Low Density Lipoprotein Cholesterol beta-Lipoprotein Cholesterol Cholesterol, beta-Lipoprotein beta Lipoprotein Cholesterol LDL Cholesterol Cholesteryl Linoleate, LDL Cholesteryl Linoleate, LDL LDL Cholesteryl Linoleate

Below are MeSH descriptors whose meaning is more general than "Cholesterol, LDL".

Chemicals and Drugs [D]
Polycyclic Compounds [D04]
Fused-Ring Compounds [D04.210]
Steroids [D04.210.500]
Cholestanes [D04.210.500.247]
Sterols [D04.210.500.247.808]
Cholesterol [D04.210.500.247.808.197]
Cholesterol, LDL [D04.210.500.247.808.197.244]
Lipids [D10]
Lipoproteins [D10.532]
Lipoproteins, LDL [D10.532.515]
Cholesterol, LDL [D10.532.515.500]
Membrane Lipids [D10.570]
Sterols [D10.570.938]
Cholesterol [D10.570.938.208]
Cholesterol, LDL [D10.570.938.208.275]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Lipoproteins [D12.776.521]
Lipoproteins, LDL [D12.776.521.550]
Cholesterol, LDL [D12.776.521.550.500]

Below are MeSH descriptors whose meaning is related to "Cholesterol, LDL".

Below are MeSH descriptors whose meaning is more specific than "Cholesterol, LDL".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Cholesterol, LDL" by people in this website by year, and whether "Cholesterol, LDL" was a major or minor topic of these publications.

Bar chart showing 149 publications over 29 distinct years, with a maximum of 14 publications in 2014

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	0	1	1
1997	1	0	1
1998	1	0	1
1999	0	2	2
2000	0	1	1
2001	0	1	1
2002	3	5	8
2003	2	8	10
2004	3	4	7
2005	3	6	9
2006	2	7	9
2007	0	3	3
2008	3	7	10
2009	1	0	1
2010	1	2	3
2011	1	7	8
2012	1	2	3
2013	4	6	10
2014	6	8	14
2015	2	3	5
2016	1	2	3
2017	3	3	6
2018	2	3	5
2019	3	0	3
2020	4	5	9
2021	1	2	3
2022	0	10	10
2023	0	2	2
2024	0	1	1

Below are the most recent publications written about "Cholesterol, LDL" by people in Profiles.

Gidding SS, Ballantyne CM, Cuchel M, de Ferranti S, Hudgins L, Jamison A, McGowan MP, Peterson AL, Steiner RD, Uveges MK, Wang Y. It is Time to Screen for Homozygous Familial Hypercholesterolemia in the United States. Glob Heart. 2024; 19(1):43.

View in: PubMed
Gidding SS. Childhood Screening for Familial?Hypercholesterolemia: JACC Review Topic of the Week. J Am Coll Cardiol. 2023 10 10; 82(15):1558-1563.

View in: PubMed
Berry ASF, Jones LK, Sijbrands EJ, Gidding SS, Oetjens MT. Subtyping Severe Hypercholesterolemia by Genetic Determinant to Stratify Risk of Coronary Artery Disease. Arterioscler Thromb Vasc Biol. 2023 10; 43(10):2058-2067.

View in: PubMed
Gidding SS, Wiegman A, Groselj U, Freiberger T, Peretti N, Dharmayat KI, Daccord M, Bedlington N, Sikonja J, Ray KK, Santos RD, Halle M, Tokg?zoglu L, Guti?rrez-Ibarluzea I, Pinto FJ, Geanta M. Paediatric familial hypercholesterolaemia screening in Europe: public policy background and recommendations. Eur J Prev Cardiol. 2022 12 21; 29(18):2301-2311.

View in: PubMed
Laffin LJ, Bruemmer D, Garcia M, Brennan DM, McErlean E, Jacoby DS, Michos ED, Ridker PM, Wang TY, Watson KE, Hutchinson HG, Nissen SE. Comparative Effects of Low-Dose Rosuvastatin, Placebo, and Dietary Supplements on Lipids and Inflammatory?Biomarkers. J Am Coll Cardiol. 2023 01 03; 81(1):1-12.

View in: PubMed
Desai NR, Farbaniec M, Karalis DG. Nonadherence to lipid-lowering therapy and strategies to improve adherence in patients with atherosclerotic cardiovascular disease. Clin Cardiol. 2023 Jan; 46(1):13-21.

View in: PubMed
Rossini E, Biscetti F, Rando MM, Nardella E, Cecchini AL, Nicolazzi MA, Covino M, Gasbarrini A, Massetti M, Flex A. Statins in High Cardiovascular Risk Patients: Do Comorbidities and Characteristics Matter? Int J Mol Sci. 2022 Aug 18; 23(16).

View in: PubMed
Hoshi RA, Liu Y, Luttmann-Gibson H, Tiwari S, Giulianini F, Andres AM, Watrous JD, Cook NR, Costenbader KH, Okereke OI, Ridker PM, Manson JE, Lee IM, Vinayagamoorthy M, Cheng S, Copeland T, Jain M, Chasman DI, Demler OV, Mora S. Association of Physical Activity With Bioactive Lipids and Cardiovascular Events. Circ Res. 2022 08 05; 131(4):e84-e99.

View in: PubMed
Jones LK, Chen N, Hassen DA, Betts MN, Klinger T, Hartzel DN, Veenstra DL, Spencer SJ, Snyder SR, Peterson JF, Schlieder V, Sturm AC, Gidding SS, Williams MS, Hao J. Impact of a Population Genomic Screening Program on Health Behaviors Related to Familial Hypercholesterolemia Risk Reduction. Circ Genom Precis Med. 2022 10; 15(5):e003549.

View in: PubMed
Schafer JJ, Zimmerman M, Walshe C, Cerankowski J, Shimada A, Keith SW. Weight changes in patients with sustained viral suppression switching tenofovir disoproxil fumarate to tenofovir alafenamide. Obesity (Silver Spring). 2022 Jun; 30(6):1197-1204.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement